ArticleAnimal feed science and technology2025
Use of melatonin plus citrulline or arginine to mitigate ergot alkaloid-induced vasoconstriction in sheep.
Article in Animal feed science and technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Fescue toxicosis, a form of ergotism, causes chronic vasoconstriction in livestock that negatively impact livestock performance. Melatonin, citrulline, and arginine have all been previously associated with vasodilation. The objective of this experiment was to evaluate dosing of melatonin, melatonin + citrulline, and melatonin + arginine in sheep as potential supplements to offset the vasoconstriction caused by toxic tall fescue seed (E + ). Eighteen Suffolk lambs were randomly divided across 3 treatments: melatonin (MEL), MEL+citrulline drench (MEL-CIT) and MEL+arginine drench (MEL-ARG). Jugular blood samples and Doppler ultrasound measurements of carotid artery were taken daily for 12 days. Lambs only received a total mixed ration (TMR) on d 1-3, on d 4-6, lambs received TMR plus E + seed and on d 7-12 lambs received MEL, MEL+CIT, or MEL+ARG. For all 3 treatments, supplementation of MEL resulted in large increases in plasma melatonin on d 7-12 compared to d 1-6 (P < 0.05). The MEL+CIT resulted in 2- to 3-fold increase in plasma citrulline compared to the other 2 treatment groups (P < 0.05). Plasma arginine was greater in MEL+CIT and MET+ARG lambs on d 7 and 8 than MEL (P < 0.05). There was a steady decline in heart rate and luminal area associated across days with initiation of E + seed dosing (P < 0.01) and did not differ across treatment groups. Conversely, velocity increased with E + seed dosing (P < 0.01) and did not differ when treatments were administered. There was no significant effect of treatment on carotid artery blood flow. Increases in plasma melatonin, arginine, or citrulline did not offset vasoconstriction associated with ergot alkaloids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.